Robert W. Baird Cuts AdaptHealth (NASDAQ:AHCO) Price Target to $14.00

AdaptHealth (NASDAQ:AHCO) had its price objective lowered by Robert W. Baird from $16.00 to $14.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Separately, Royal Bank of Canada restated an “outperform” rating and set a $13.00 price target on shares of AdaptHealth in a research report on Monday, August 12th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.17.

AdaptHealth Trading Up 2.6 %

AHCO stock opened at $10.09 on Wednesday. The company’s 50-day simple moving average is $10.70 and its 200-day simple moving average is $10.44. The company has a quick ratio of 0.94, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. AdaptHealth has a 52-week low of $6.43 and a 52-week high of $11.90. The firm has a market cap of $1.36 billion, a P/E ratio of -6.12, a PEG ratio of 1.58 and a beta of 1.11.

AdaptHealth (NASDAQ:AHCO) last posted its earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.02). AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The firm had revenue of $805.90 million for the quarter, compared to analysts’ expectations of $809.32 million. During the same period in the previous year, the company earned $0.19 earnings per share. The company’s revenue was up .2% compared to the same quarter last year. As a group, equities analysts forecast that AdaptHealth will post 0.87 EPS for the current fiscal year.

Insiders Place Their Bets

In other AdaptHealth news, Director David Solomon Williams III sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total value of $45,040.00. Following the transaction, the director now directly owns 36,899 shares of the company’s stock, valued at $415,482.74. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director David Solomon Williams III sold 4,000 shares of AdaptHealth stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total transaction of $45,040.00. Following the sale, the director now owns 36,899 shares of the company’s stock, valued at approximately $415,482.74. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Shaw Rietkerk sold 25,000 shares of AdaptHealth stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $11.24, for a total transaction of $281,000.00. Following the sale, the chief operating officer now directly owns 212,611 shares in the company, valued at approximately $2,389,747.64. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.43% of the company’s stock.

Institutional Trading of AdaptHealth

Several institutional investors have recently made changes to their positions in AHCO. Janney Montgomery Scott LLC raised its position in shares of AdaptHealth by 80.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 27,949 shares of the company’s stock valued at $322,000 after buying an additional 12,430 shares during the period. Texas Permanent School Fund Corp increased its holdings in AdaptHealth by 1.4% in the 1st quarter. Texas Permanent School Fund Corp now owns 71,201 shares of the company’s stock valued at $820,000 after purchasing an additional 979 shares during the last quarter. Empowered Funds LLC increased its holdings in AdaptHealth by 8.2% in the 1st quarter. Empowered Funds LLC now owns 502,762 shares of the company’s stock valued at $5,787,000 after purchasing an additional 38,084 shares during the last quarter. SG Americas Securities LLC acquired a new stake in AdaptHealth in the 1st quarter valued at approximately $129,000. Finally, Sei Investments Co. acquired a new stake in AdaptHealth in the 1st quarter valued at approximately $2,365,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.